Loading…
Sun Pharmaceutical Industries (SUNPHARMA)₹1,905−0.55%Pharmaceuticals
At the end of the Sep 2026 quarter, Sun Pharmaceutical Industries' shareholders were: promoters 52.65%, FIIs 14.34%, DIIs 22.29%, public 10.72%. Promoter holding is down 1.80 percentage points from 54.45% a quarter earlier. FII holding is down 2.19 percentage points from 16.53% a year earlier. 1.67% of promoter shares were pledged. It had 7,14,132 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 54.45% | 54.45% | 54.45% | 54.45% | 54.45% | 54.45% | 54.45% | 54.45% | 54.45% | 54.45% | 54.45% | 52.65% |
| FIIs | 17.06% | 17.70% | 17.21% | 17.99% | 18.02% | 17.94% | 17.24% | 16.53% | 16.10% | 15.92% | 14.52% | 14.34% |
| DIIs | 19.44% | 18.73% | 19.19% | 18.50% | 18.45% | 18.60% | 19.40% | 20.14% | 20.74% | 21.02% | 22.08% | 22.29% |
| Government | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.00% |
| Public | 8.94% | 9.01% | 9.04% | 8.95% | 8.97% | 8.90% | 8.80% | 8.77% | 8.60% | 8.50% | 8.84% | 10.72% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 1.67% |
| Number of shareholders | 6,12,511 | 6,31,273 | 6,73,090 | 6,57,193 | 6,89,493 | 7,04,850 | 7,23,634 | 7,43,737 | 7,10,766 | 6,90,827 | 7,10,112 | 7,14,132 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Shanghvi Finance Private Limited | Promoter | 40.32% | 0.00 |
| Dilip.S.Shanghvi | Promoter | 9.57% | 0.00 |
| Life Insurance Corporation Of India | DII | 5.37% | −0.21 |
| Icici Prudential Value Fund | DII | 3.23% | −0.51 |
| Sbi Nifty 50 Etf | DII | 2.84% | +0.46 |
| Nps Trust- A/C Hdfc Pension Fund Management Limited Scheme E - Tier I | DII | 1.95% | +0.08 |
| Aditya Medisales Limited | Promoter | 1.68% | 0.00 |
| Nippon Life India Trustee Ltd-A/C Nippon India Etf Nifty 50 Bees | DII | 1.31% | New |
| Raksha Sudhir Valia | Public | 1.21% | New |
| Hdfc Trustee Company Ltd. A/C Hdfc Balanced Advantage Fund | DII | 1.13% | New |
| Lakshdeep Investments & Finance (P) Ltd. | Public | 1.03% | 0.00 |
| Government Pension Fund Global | FII | 1.00% | −0.02 |
| Unimed Investments Limited | Promoter | 0.43% | 0.00 |
| Vibha Dilip Shanghvi | Promoter | 0.37% | 0.00 |
| Aalok Dilip Shanghvi | Promoter | 0.12% | 0.00 |
| Vidhi Dilip Shanghvi | Promoter | 0.12% | 0.00 |
| Shanghvi Family & Friends Benefit Trust | Promoter | 0.05% | 0.00 |
| Nippon Life India Trustee Ltd-A/C Nippon India Large Cap Fund | DII | Exited | — |
| Raksha Sudhir Valia | Promoter | Exited | — |
| Sudhir Vrundavandas Valia | Promoter | Exited | — |
| Kumud Shantilal Shanghvi | Promoter | 0.00% | 0.00 |
Promoters held 52.65% of Sun Pharmaceutical Industries at the end of the Sep 2026 quarter, down 1.80 percentage points from 54.45% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 14.34% (down 0.18 percentage points from 14.52% a quarter earlier) and domestic institutions (DIIs) held 22.29% (up 0.21 percentage points from 22.08% a quarter earlier).
Yes. 1.67% of promoter shares were pledged at the end of the Sep 2026 quarter.
Sun Pharmaceutical Industries had 7,14,132 shareholders at the end of the Sep 2026 quarter, against 7,43,737 a year earlier.
Life Insurance Corporation Of India (DII) held 5.37% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.